Figure 4.
Average decrease in systolic blood pressure (δSBP) produced by 1 mg/min of the ganglionic blocker trimethaphan in patients with multiple‐system atrophy (MSA) and pure autonomic failure (PAF)
Average decrease in systolic blood pressure (δSBP) produced by 1 mg/min of the ganglionic blocker trimethaphan in patients with multiple‐system atrophy (MSA) and pure autonomic failure (PAF)